Zobrazeno 1 - 10
of 305
pro vyhledávání: '"Charles W. Francis"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Venous thromboembolism (VTE) is a common complication in cancer patients, resulting in deep vein thrombosis (DVT) or pulmonary embolism (PE), and is responsible for high morbidity and mortality. This article discusses evidence and future per
Externí odkaz:
https://doaj.org/article/b0ec03b78f204f39a6b9fc05562434ff
Autor:
Laurence S Magder, PJ Devereaux, Diane Smith, Laurence Magder, David J Warwick, Samuel Z Goldhaber, Jay S Magaziner, James A Browne, John Eikelboom, Rebecca Baron, Patrick Heagerty, Stephen L Kates, Vincent D Pellegrini, Jr, John William Eikelboom, C McCollister Evarts, Patricia D Franklin, Kevin L Garvin, Richard Iorio, Carol Ann Lambourne, Jay Magaziner, Eric M Cohen, Charles M Davis, Navin D Fernando, Kevin B Fricka, Richard J Friedman, Kevin L. Garvin, Michael S Kain, Brent A Lanting, Brock A Lindsey, William J Maloney, Robert M Molloy, Michael A Mont, Wayne E Moschetti, James Nace, Charles L Nelson, Kevin I Perry, James D Slover, Mark J Spangehl, Lawrence M Specht, Scott M Sporer, Robert S Sterling, Zeke J Walton, William L Healy, Charles W Francis, Vincent D Pellegrini, Monica Baczko, Carol A Lambourne, Brook I Martin, Ronald Blankstein, Carolyn Come, Jean Connors, Raymond Kwong, Greg Piazza, Rachel Rosovsky, Aaron Waxman, Roger Bulger, Ruth Bulger, Mary Beth Crummer, Debra Hamilton, Connie Persels, Robert Schlegel, Sally Seeley, Mitchell Thompson, Teresa Bordeaux, Kathryn Z Mikkelsen, Lisa K Moores
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/c21d8bdb9eae4552a920adbd09818605
Autor:
James Ryan Loftus, Deborah J. Rubens, Burke R Morin, Zhongxia Hu, Katherine Kaproth-Joslin, Charles W. Francis, Alok A. Khorana, Susan K. Hobbs
Publikováno v:
Journal of Ultrasound in Medicine. 41:225-236
Objectives We retrospectively examined the venous thromboembolism (VTE) events diagnosed in the Prophylaxis of High-Risk Ambulatory Cancer Patients Study (PHACS), a multi-center randomized trial, to assess the value of screening vascular imaging for
Autor:
Fisseha Tesfaye, Michael R. Lassen, John Strony, Renée M Swaim, Jeffrey I. Weitz, Gary Peters, Gary E. Raskob, Lee Michael, Peter M DiBattiste, Charles W. Francis, Annelise Segers, Takeshi Fuji, Robin S. Roberts
Publikováno v:
Journal of Thrombosis and Haemostasis
BACKGROUND JNJ-9375 is an antibody against exosite 1 on thrombin, inhibits substrate binding but not catalytic activity. OBJECTIVE To examine the possibility that JNJ-9375 attenuates thrombosis without affecting hemostasis, we compared the efficacy a
Autor:
Ali Shamseddine, Juan I. Arcelus, Isabel Bogalho, Jérôme Connault, Hans Stricker, Maral Koolian, Ali Bazarbachii, Susan Solymoss, Andre Roussin, Thierry André, Gerald A. Soff, Stéphane Villiers, Enrique Gallardo, Ingrid Pabinger, Michel Nguessan, Marc Philip Righini, Hanno Riess, Joseph Emmerich, Pantep Angchaisuksiri, Dorit Blickstein, Ajay K. Kakkar, Dialina Brilhante, Pedro Ruiz-Artacho, Kenneth A. Bauer, Hugo A. Clemente, Emmanuel Messas, Walter Ageno, Anthony Marayevas, Anna Falanga, Vanessa Pachon Olmos, José Antonio Rueda-Camino, Sanjith Saseedharan, Javier Trujillo-Santos, Alexander Makatsariya, Arlette Ndour, Toutou Toussaint, Vicky Tagalakis, Hanadi Rafii, Raymond S.M. Wong, Fernando Ajauro, Antonio Moreira, Henri Bounameaux, Russel D. Hull, Ellis Martin, Florian Posch, Isabelle Madelaine, Joydeep Chakbrabartty, Mark Blostein, Kamal R. Al-Aboudi, Patricia Casais, Thierry Alcindor, Mario Mandalà, Corinne Frere, Lai Heng Lee, Eric Assenat, Ahmet M. Demir, Christine Marosi, Carme Font, Cecilia Guillermo, Luis Meillon, Viktoria Bitsadze, Ana Pais, Luisa Lopes Dos Santos, Ludovic Doucet, Thomas Gary, Andrés Muñoz, Ali T. Taher, Luis Jara-Palomares, Norizaku Yamada, Takayuki Ikezoe, Matthias Preusser, Cécile Durant, Jamilya Khrizroeva, Zora Marjanovic, Barbara Bournet, James D. Douketis, Clemens Feistritzer, Remedios Otero-Candelera, Alok A. Khorana, Jean-Christophe Gris, I. Benzidia, Nigel S. Key, A. Hij, Ramón Lecumberri, Cynthia Rothschild, Duarte Henrique Machado, Manuel Monreal, Jan Beyer-Westendorf, Jean M. Connors, Florian Langer, Darko Antic, Gabriela Cesarman-Maus, Dominique Farge, Benjamin Brenner, Antoine F. Carpentier, Charles W. Francis, Howard A. Liebman, Cihan Ay
Publikováno v:
The Lancet Oncology
The Lancet Oncology, 2019, 20 (10), pp.e566-e581. ⟨10.1016/S1470-2045(19)30336-5⟩
The Lancet Oncology, Vol. 20, No 10 (2019) pp. e566-e581
The Lancet Oncology, 2019, 20 (10), pp.e566-e581. ⟨10.1016/S1470-2045(19)30336-5⟩
The Lancet Oncology, Vol. 20, No 10 (2019) pp. e566-e581
International audience; Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at a high risk of VTE recurrence and bleeding during anticoagulant therapy. The International Initiative on Thrombos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7672e7f992559d028de7a6176f76ebeb
https://hal.sorbonne-universite.fr/hal-02394158
https://hal.sorbonne-universite.fr/hal-02394158
Autor:
Alok A. Khorana, Charles W. Francis
Publikováno v:
Thrombosis Research. 164:S70-S76
Cancer-associated venous thromboembolism (VTE) has major consequences for patients, including morbidity and risk of mortality. However, there is substantial variation in risk depending on a multitude of clinical risk factors and many cancer patients
Autor:
Grace Conley, Saadia Sherazi, Eugene Muchnik, Brent A. Johnson, Peter A. Kouides, H.T. Massey, Charles W. Francis, Charles J. Lowenstein, Majed A. Refaai, Jeffrey D. Alexis, Susan Lien
Publikováno v:
The International Journal of Artificial Organs. 41:269-276
Background: Bleeding is a major cause of morbidity in patients with continuous flow left ventricular assist devices (LVADs). We sought to identify clinical predictors of bleeding within the first year of LVAD implantation. Methods: A prospective stud
Autor:
Brynja R. Gudmundsdottir, Olafur S. Indridason, Pall T. Onundarson, Charles W. Francis, Hulda M. Jensdottir, David O. Arnar, Brynjar Vidarsson, Sigrun H. Lund, Alma R. Oskarsdottir, Magnus K. Magnusson, Einar Bjornsson
Publikováno v:
Journal of Thrombosis and Thrombolysis. 43:550-561
Fiix-prothrombin time (Fiix-PT) differs from traditional PT in being affected by reduced factor (F) II or FX only. In the randomized controlled Fiix-trial, patients on warfarin monitored with Fiix-PT (Fiix-warfarin patients) had fewer thromboembolism
Publikováno v:
International Journal of Laboratory Hematology. 39:e10-e13
Autor:
Pall T. Onundarson, Brynja R. Gudmundsdottir, Sigurdur Juliusson, Petur I. Jonsson, Charles W. Francis, Loic Letertre
Publikováno v:
Journal of Thrombosis and Haemostasis. 15:131-139
Background The prothrombin time (PT) is equally prolonged by reduction in each of vitamin K dependent (VKD) factors (F) II, VII and X. The Fiix-PT is only affected by FII and FX, the main contributors to thrombin generation (TG). Objective To test th